Jianfan Biotech released its three-quarter report on the evening of October 18. In the first three quarters of 2024, it achieved operating revenue of 2.196 billion yuan, an increase of 47.76% over the previous year; net profit of 792 million yuan, an increase of 86.86% over the previous year. Among them, the third quarter achieved revenue of 700 million yuan, up 47.74% year on year; net profit of 239 million yuan, up 63.62% year on year; revenue growth was mainly due to rapid growth in revenue from perfuser and adsorber products.

Jianfan Biotech released its three-quarter report on the evening of October 18. In the first three quarters of 2024, it achieved operating revenue of 2.196 billion yuan, an increase of 47.76% over the previous year; net profit of 792 million yuan, an increase of 86.86% over the previous year. Among them, the third quarter achieved revenue of 700 million yuan, up 47.74% year on year; net profit of 239 million yuan, up 63.62% year on year; revenue growth was mainly due to rapid growth in revenue from perfuser and adsorber products.